CRMD 8-K 2026-11-09

CorMedix Inc. (CRMD) 8-K dated 2026-11-09 — accession 0001213900-26-117213.

CorMedix Inc. (CRMD) is a biotechnology company listed on US.

CorMedix Inc. filed a 8-K on 2026-11-09. Accession 0001213900-26-117213.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRMD revenue for 2025-12-31 was $311.7M. Net income was $163.1M. Revenue was up 617.0% from 2024-12-31 to 2025-12-31. CRMD currently screens at market cap $655.9M.

Not investment advice. The CRMD SEC hub lists recent forms. The stock page is the research view.